Medical Research
December 15, 2022 | Personalis and the University of California, San Francisco (UCSF) have announced a collaboration that will deploy a personalized liquid biopsy-based research use only (RUO) assay for a study of patients with colorectal...
Penn led the largest global effort to identify and predict GBM tumor boundaries without compromising patient privacy. PHILADELPHIA— Researchers at Penn Medicine and Intel Corporation led the largest-to-date global machine...
Proscia: Retrospective study demonstrated 56.3% increase in melanoma detection sensitivity through use of contrastive self-supervised learning PHILADELPHIA – November 15, 2022 – Proscia®, a leading provider of digital and computational...
TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, a leader in AI-powered spatial biology, today announced the expansion of its spatial biology platform to include a new generation of multiplex immunofluorescence (mIF) analysis that uses deep learning...
Proscia: Findings illustrate promise of technology to lower misdiagnosis rate for deadliest form of skin cancer PHILADELPHIA – November 1, 2022 – Proscia®, a leading provider of digital and computational pathology solutions, has released...
In recent years, artificial intelligence developers have changed the face of medicine with algorithms capable of detecting the earliest signs of cancer. Owkin, meanwhile, is taking a slightly different approach with its own cancer-spotting...
